Schedule 13G ownership disclosure

CITIUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 17322U207

Event date: 2018-08-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-18-005766
Form type
SC 13G
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Aug 20, 2018
Reporting period
Aug 08, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub